ADC Therapeutics SA
ADCT· NYSE· Pharmaceutical Preparations
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- -173.8%
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- –
We record prices for the companies we cover; ADCT is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 127.1M
- Revenue
- $81.4M
- Free cash flow
- -$141.4M
- Owner earnings
- -$148.3M
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- –
- Operating
- -149.3%
- Net
- -175.3%
- Free cash flow
- -173.8%
- Owner earnings
- -182.3%
- Stock pay
- 8.5%
Returns
- ROIC, FY2025
- –
- ROIC, 5 yr avg
- –
- ROE, FY2025
- –
- ROE, 5 yr avg
- –
Growth (CAGR)
- Revenue, 3 yr
- 2.8%
- Revenue, 5 yr
- –
- Diluted EPS, 3 yr
- –
- Diluted EPS, 5 yr
- –
- Free cash flow, 3 yr
- –
- Free cash flow, 5 yr
- –
Financial health · FY2025
- Cash and investments
- $261.3M
- Total debt
- –
- Net cash
- –
- Debt/Equity
- –
- Debt/FCF
- –
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- –
Financials: ten years from the 10-Ks
Revenue
$81.4M
+2.8% a year over 3 years
FY2022FY2025
Margins
Operating-149.3%Net-175.3%
FY2025
FY2022FY2025
Free cash flow and owner earnings
Free cash flow-$141.4MOwner earnings-$148.3M
FY2025
FY2022FY2025
Diluted shares
127.1M
+62.6% over 3 years, net dilution
FY2022FY2025
Every figure, year by year
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| The business | ||||
| Revenue | $74.9M | $69.1M | $70.8M | $81.4M |
| Revenue growth | – | -7.8% | 2.6% | 14.9% |
| Gross margin | – | – | – | – |
| Operating margin | -164.7% | -240.4% | -184.4% | -149.3% |
| Net income | -$157.1M | -$240.1M | -$157.8M | -$142.6M |
| Net margin | -209.8% | -347.6% | -222.8% | -175.3% |
| Diluted EPS | $-2.01 | $-2.94 | $-1.62 | $-1.12 |
| Return on invested capital? | – | – | – | – |
| Cash | ||||
| Operating cash flow | -$138.3M | -$118.7M | -$123.8M | -$141.2M |
| Capital expenditure | $687.0K | $3.2M | $867.0K | $264.0K |
| Free cash flow | -$139.0M | -$121.9M | -$124.7M | -$141.4M |
| Stock-based compensation | $49.3M | $13.5M | $6.6M | $6.9M |
| Owner earnings? | -$188.3M | -$135.4M | -$131.3M | -$148.3M |
| Free cash flow per share | $-1.78 | $-1.49 | $-1.28 | $-1.11 |
| Capital allocation | ||||
| Dividends paid | – | – | – | – |
| Share repurchases | – | – | – | – |
| Diluted shares | 78.2M | 81.7M | 97.2M | 127.1M |
| Share count change? | – | 4.6% | 18.9% | 30.8% |
| Balance sheet | ||||
| Cash and equivalents | $326.4M | $278.6M | $250.9M | $261.3M |
| Short-term investments | – | – | – | – |
| Total debt | – | – | – | – |
| Net debt | – | – | – | – |
| Shareholders' equity | $79.5M | -$148.2M | -$202.6M | -$185.8M |
Latest filings
| 2026-10-13 | 8-K | Earnings release |
| 2026-08-13 | 10-Q | Quarterly report |
| 2026-08-13 | 8-K | Earnings release |
| 2026-05-04 | 10-Q | Quarterly report |
| 2026-05-04 | 8-K | Earnings release |
| 2026-04-20 | DEF 14A | Proxy statement |
| 2026-03-10 | 10-K | Annual report |
| 2026-03-10 | 8-K | Earnings release |
| 2026-01-08 | 8-K | Earnings release |
| 2025-11-10 | 10-Q | Quarterly report |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
